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‘Smart’ matrix (engECM), composed of hyaluronan and recombinant fibronectin functional
domains, promotes robust en masse migration of adult human dermal fibroblasts and in vivo
wound repair.
Kaustabh Ghosh1, Xiang-Dong Ren2, Xiao Zheng Shu3, Glenn D. Prestwich3 and Richard A.F.
Clark1,2
1Department of Biomedical Engineering, SUNY Stony Brook, Stony Brook, New York, USA;
2Department of Dermatology, SUNY Stony Brook, Stony Brook, New York, USA and
3Department of Medicinal Chemistry, University of Utah, Salt Lake City, Utah, USA
Injured tissue heals when tissue cells receive the proper signals for regeneration or repair. A
plethora of engECM formulations have utilized synthetic or semisynthetic polymers rendered
biologically active by tethered RGD, a cell binding tripeptide. Although transformed cell lines
attach, spread and proliferate on or within these biomaterials, there is a paucity of data on their
ability to influence primary human cell strains. Even less information exists regarding the ability of
engECM to facilitate cell migration, a process critical for wound repair. Here, we report a novel
3D engECM that promotes robust en masse migration of adult human dermal fibroblast.
Hydrogels were formulated by coupling three recombinant fibronectin functional domains,
previously shown to be necessary and sufficient for optimal human fibroblast migration on a 2D
surface, to thiolated hyaluronan using a polyethylene divinylsulfone crosslinker. En masse
migration of adult human dermal fibroblast on engECM decorated with the three recombinant
fibronectin functional domains was a function of recombinant fibronectin functional domains
type and dose. In contrast, adult human dermal fibroblast failed to spread and migrate on
synthetic RGD-tethered engECM. The en masse migration of adult human dermal fibroblastss on
our engECM in vitro is similar to that observed during rapid granulation tissue formation in
healing wounds. Our engECM also promoted such response in vivo. These data suggest that
recombinant fibronectin functional domainspolyethylene divinylsulfone-hyaluronan may be
effective in treatment of non-healing wounds.
Adenosine A2A receptors and dermal fibrosis: a pathogenic role for adenosine in diffuse dermal
fibrosis.
E. S. L. Chan1, P. Fernandez1, A. A. Merchant1, A. Desai1, M. C. Montesinos1, C. F. Tung1, D. N.
Khoa1, M. H. Pillinger1, A. B. Reiss2, M. Tomic-Canic1, J. F. Chen3, M. A. Schwarzschild4 and
B. N. Cronstein1
1New York University School of Medicine, New York, New York, USA; 2Winthrop University
Hospital, Mineola, New York, USA; 3Boston University School of Medicine, Boston,
Massachusetts, USA and 4Massachusetts General Hospital and Harvard Medical School, Boston,
Massachusetts, USA
Adenosine is a potent endogenous regulator of inflammation and tissue repair. As adenosine A2A
receptors stimulate dermal wound healing, in part, by stimulating collagen matrix production, we
examined whether adenosine A2A receptors also contribute to the pathogenesis of dermal fibrosis.
Collagen production by primary human dermal fibroblasts was analyzed by 14C-proline
incorporation. Intracellular signaling of dermal collagen production upon adenosine A2A receptor
stimulation was investigated using inhibitors of MEK-1 and by direct demonstration of stimulated
extracellular signal-regulated kinase phosphorylation. The role of the adenosine A2A receptor in
dermal fibrosis was studied in a bleomycin-induced (1 mg SQ, on alternate days for 18 days)
model of scleroderma in adenosine A2A receptor-deficient, wild-type littermate mice and C57BL6
mice, as well as C57BL6 mice treated with an adenosine A2A receptor antagonist (ZM241385,
50 mg/kg in dimethylsulphoxide/cremophore, administered intraperitoneally twice a day). Skin
thickness, skin-fold thickness, skin breaking tension, and dermal collagen (hydroxyproline)
content were determined as measures of dermal fibrosis in control or bleomycin-treated mice.
Adenosine A2A receptor occupancy promoted collagen production by primary human dermal
fibroblasts and this process was blocked by an antagonist to the adenosine A2A, but not A1 or A2B
receptor. Adenosine A2A receptor ligation stimulated extracellular signal-regulated kinase
phosphorylation and A2A receptor-mediated promotion of collagen production by dermal
fibroblasts was blocked by inhibitors of MEK-1. Adenosine A2A receptor-deficient mice and
adenosine A2A receptor antagonist-treated mice were completely protected from development of
dermal fibrosis following exposure to bleomycin.
In conclusion, these results demonstrate that adenosine A2A receptors play an active role in the
pathogenesis of dermal fibrosis and suggest a novel therapeutic target in the treatment and
prevention of dermal fibrosis in diseases such as scleroderma.
Effect of elevated polyamine biosynthesis in cutaneous wound healing.
Candace Sewter1, Karen DeFeo1, Rebecca Morris2 and Susan Gilmour1
1Lankenau Institute for Medical Research, Wynnewood, Pennsylvania, USA and
2Columbia University, New York, New York, USA
Characterization of the ornithine decarboxylase (ODC)/ER2-inducible transgenic mouse, in
which ODC is expressed de novo in the adult suprabasal epidermis, has revealed that induction of
ODC activity following topical treatment with the inducer 4-hydroxytamoxifen stimulates both
epidermal proliferation and differentiation resulting in only moderate hyperplasia. Although ODC
activity is directed to suprabasal epidermal cells, cells in the dermis are activated as well.
Following 4-hydroxytamoxifen treatment, deposition of extracellular matrix proteins such as
tenascin-C and collagen increases in the dermis of ODC/ER2 transgenic mice accompanied by a
diminution of the fat layer and increased vascularization. These results suggest that de novo
suprabasal epidermal induction of ODC activity activates both keratinocytes and dermal
components in a manner similar to skin undergoing wound healing. Skin abrasion experiments
with 4-hydroxytamoxifen-treated ODC/ER2 mice demonstrate sustained epidermal hyperplasia,
stromal activation, and increased vascularization 2 weeks following wounding compared to
similarly abraded 4-hydroxytamoxifen-treated normal mice and ethanol-treated ODC/ER2
transgenic mice. As most tumors possess elevated ODC levels, it is likely that the wound healing
phenotype induced by increased polyamine biosynthesis, as seen in ODC/ER2 transgenic mice,
creates a more permissive microenvironment for the expansion of dormant, genetically altered
epithelial cells to a malignant phenotype. (Supported by NIH grant CA070739.)
EGF modulates slug expression during cutaneous wound re epithelialization
The Slug transcription factor is essential for effective cutaneous wound reepithelialization both
in vitro and in vivo.
Donna F. Kusewitt1, Changsun Choi1 and Laurie G. Hudson2
The Ohio State University College of Veterinary Medicine, Columbus, Ohio, USA and The
University of New Mexico College of Pharmacy, Albuquerque, New Mexico, USA
Enhanced expression of Slug at cutaneous wound margins is associated with decreased cell:cell
adhesion and enhanced keratinocyte motility. The role that Slug plays in cutaneous wound
healing is reminiscent of its role in epithelial mesenchymal transformation during embryogenesis.
During development, expression of Slug is modulated by a variety of growth factors, including
transforming growth factor-b and basic fibroblast growth factor; therefore, we investigated the
role of growth factors in modulating Slug expression during cutaneous wound reepithelialization.
Human keratinocytes were treated with a variety of growth factors, and expression levels of Slug
and the related transcription factor Snail were determined by quantitative reverse transcription-
PCR. Several growth factors, including epidermal growth factor (EGF), keratinocyte growth factor,
IGF-1, and basic fibroblast growth factor, enhanced Slug expression. Of the growth factors tested,
EGF was the most effective at enhancing Slug expression and was the only one that enhanced
Snail expression. We further examined the importance of EGF-stimulated Slug expression in
cutaneous wound healing in skin explants from wild-type mice, mice homozygous for an
inactivated Slug gene (Slug-lacZ), and mice heterozygous for the Slug-lacZ allele. Administration
of exogenous EGF accelerated epithelial outgrowth from explants and enhanced Slug expression
in migrating cells. In the presence of the EGF receptor inhibitor AG1478, explant outgrowth and
Slug expression were markedly inhibited. There was no outgrowth from Slug knockout explants,
even in the presence of exogenous EGF. These findings suggest that EGF enhances cutaneous
wound reepithelialization by stimulating expression of the Slug transcription factor.
A keratinocyte wound-related hypermotility and p16INK4A growth arrest response activated by
the c2 precursor form of laminin 5 and regulated by the TGF-b receptor.
Easwar Natarajan, Zongyou Guo, John D. Omobono II, Alexander Lazar, Thomas Brenn, Jonathan
C. Jones and James G. Rheinwald
Departments of Dermatology and Pathology, Brigham and Women’s Hospital, Harvard Skin
Disease Research Center, Harvard Medical School, Boston, Massachusetts, USA and North-
western University Medical School, Chicago, Illinois, USA
We have reported previously that the replicative lifespan of primary human keratinocytes in
culture is limited by a telomere-unrelated, stochastic induction of the cell cycle inhibitor p16INK4A
(p16) and that senescent, p16-positive keratinocytes also display an increased expression of the
basement membrane protein Laminin 5 (Lam5) and a remarkable directional hypermotility. We
report here that that coordinate expression of Lam5 and p16 occurs at the migrating front of
keratinocytes in skin wounds in vivo, wounds made in organ-cultured skin, and scratch wounds
in confluent keratinocyte cultures grown on plastic. Lam5/p16 expression is also induced by
plating keratinocytes on surfaces coated with the g2 chain precursor form of Lam5 (Lam5g2pre).
Under these conditions, cells immediately exhibit a persistent, directional hypermotility of
B150mm/hour and subsequently express p16 and become irreversibly growth-arrested. Cells
plated on control surfaces in the presence of transforming growth factor-beta (TGF-b) exhibit
hypermotility after a 12–24 hours lag period. Plating cells on Lam5g2pre triggers nuclear
translocation of smad2/3-downstream effectors of TGF-b receptor activation. A TGF-b receptor I
kinase-specific drug inhibitor blocks smad2/3 translocation, hypermotility, and growth arrest in
response to TGF-b and to Lam5g2pre. A collagen I-coated surface induces a vigorous directional
hypermotility response but does not trigger smad2/3 translocation or growth arrest. Expression of
a smad4-RNAi blocks smad2/3 nuclear translocation but does not block Lam5g2pre-induced
growth inhibition or hypermotility. In contrast, drug inhibitors of several smad-independent signal
pathway kinases downstream of TGF-b receptor activation, including p38MAPK, p160ROCK, and
fyn, reduce or prevent Lam5g2pre-induced hypermotility and growth inhibition. These results
provide the fundamental molecular characterization of a coordinated hypermotility and growth
arrest response that is activated in keratinocytes during wound healing and reveal a cross-talk
between adhesion- and TGF-b-stimulated signal pathways in this cell type.
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